Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy

Clinical Immunology

Volumn 155, Issue 1, 2014, Pages 47-59

  Frischmeyer Guerrerio, Pamela A ^a   Keet, Corinne A ^a   Guerrerio, Anthony L ^a   Chichester, Kristin L ^a   Bieneman, Anja P ^a   Hamilton, Robert G ^a   Wood, Robert A ^a   Schroeder, John T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive immunity; Dendritic cell; Food allergy; Immunotherapy; Innate immunity; Tolerance

Indexed keywords

ALPHA INTERFERON; COW MILK PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; MILK PROTEIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; ALLERGEN; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; TLR2 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADOLESCENT; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INNATE IMMUNITY; MILK ALLERGY; ORAL IMMUNOTHERAPY; PLASMACYTOID DENDRITIC CELL; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL IMMUNOTHERAPY; TH2 CELL; CELL CULTURE; COCULTURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MILK HYPERSENSITIVITY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SUBLINGUAL DRUG ADMINISTRATION; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; CELLS, CULTURED; CHILD; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DOUBLE-BLIND METHOD; GENE EXPRESSION REGULATION; HUMANS; MILK HYPERSENSITIVITY; PEPTIDOGLYCAN; RECEPTORS, IGE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 84907166867     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.08.006     Document Type: Article

References (44)

1. Skripak J.M., Matsui E.C., Mudd K., Wood R.A. The natural history of IgE-mediated cow's milk allergy. J. Allergy Clin. Immunol. 2007, 120:1172-1177.
2. Savage J.H., Matsui E.C., Skripak J.M., Wood R.A. The natural history of egg allergy. J. Allergy Clin. Immunol. 2007, 120:1413-1417.
3. Kim E.H., Bird J.A., Kulis M., Laubach S., Pons L., Shreffler W., Steele P., Kamilaris J., Vickery B., Burks A.W. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J. Allergy Clin. Immunol. 2011, 127:640-646. (e641).
4. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., Shreffler W.G., Steele P., Henry K.A., Adair M., Francis J.M., Durham S., Vickery B.P., Zhong X., Burks A.W. Clinical efficacy and immune regulation with peanut oral immunotherapy. J. Allergy Clin. Immunol. 2009, 124:292-300. (300 e291-297).
5. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., Hiegel A., Kamilaris J., Carlisle S., Yue X., Kulis M., Pons L., Vickery B., Burks A.W. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J. Allergy Clin. Immunol. 2011, 127:654-660.
6. Keet C.A., Frischmeyer-Guerrerio P.A., Thyagarajan A., Schroeder J.T., Hamilton R.G., Boden S., Steele P., Driggers S., Burks A.W., Wood R.A. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J. Allergy Clin. Immunol. 2012, 129:448-455. (455 e441-445).
7. Moingeon P., Batard T., Fadel R., Frati F., Sieber J., Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006, 61:151-165.
8. Durham S.R., Ying S., Varney V.A., Jacobson M.R., Sudderick R.M., Mackay I.S., Kay A.B., Hamid Q.A. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J. Allergy Clin. Immunol. 1996, 97:1356-1365.
9. Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 2009, 123:735-746. (quiz 747-738).
10. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
11. Schreibelt G., Tel J., Sliepen K.H., Benitez-Ribas D., Figdor C.G., Adema G.J., de Vries I.J. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol. Immunother. 2010, 59:1573-1582.
12. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:3388-3393.
13. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194:863-869.
14. Frischmeyer-Guerrerio P.A., Guerrerio A.L., Chichester K.L., Bieneman A.P., Hamilton R.A., Wood R.A., Schroeder J.T. Dendritic cell and T cell responses in children with food allergy. Clin. Exp. Allergy 2011, 41:61-71.
15. Schroeder J.T., Bieneman A.P., Chichester K.L., Hamilton R.G., Xiao H., Saini S.S., Liu M.C. Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. J. Allergy Clin. Immunol. 2010, 125:896-901. (e896).
16. Huber J.P., Ramos H.J., Gill M.A., Farrar J.D. Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J. Immunol. 2010, 185:813-817.
17. + T cells. J. Exp. Med. 1997, 185:461-469.
18. Dodge I.L., Carr M.W., Cernadas M., Brenner M.B. IL-6 production by pulmonary dendritic cells impedes Th1 immune responses. J. Immunol. 2003, 170:4457-4464.
19. Kucuksezer U.C., Palomares O., Ruckert B., Jartti T., Puhakka T., Nandy A., Gemicioglu B., Fahrner H.B., Jung A., Deniz G., Akdis C.A., Akdis M. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J. Allergy Clin. Immunol. 2013, 131:875-885.
20. Tulic M.K., Hodder M., Forsberg A., McCarthy S., Richman T., D'Vaz N., van den Biggelaar A.H., Thornton C.A., Prescott S.L. Differences in innate immune function between allergic and nonallergic children: new insights into immune ontogeny. J. Allergy Clin. Immunol. 2011, 127:470-478. (e471).
21. Tversky J.R., Le T.V., Bieneman A.P., Chichester K.L., Hamilton R.G., Schroeder J.T. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin. Exp. Allergy 2008, 38:781-788.
22. Gill M.A., Bajwa G., George T.A., Dong C.C., Dougherty I.I., Jiang N., Gan V.N., Gruchalla R.S. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J. Immunol. 2010, 184:5999-6006.
23. Tversky J.R., Bieneman A.P., Chichester K.L., Hamilton R.G., Schroeder J.T. Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function. Clin. Exp. Allergy 2010, 40:94-102.
24. Allam J.P., Stojanovski G., Friedrichs N., Peng W., Bieber T., Wenzel J., Novak N. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?. Allergy 2008, 63:720-727.
25. Schroeder J.T., Bieneman A.P., Xiao H., Chichester K.L., Vasagar K., Saini S., Liu M.C. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J. Immunol. 2005, 175:5724-5731.
26. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008, 181:5396-5404.
27. de Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004, 200:89-98.
28. Smit J.J., Bol-Schoenmakers M., Hassing I., Fiechter D., Boon L., Bleumink R., Pieters R.H. The role of intestinal dendritic cells subsets in the establishment of food allergy. Clin. Exp. Allergy 2011, 41:890-898.
29. Le T., Tversky J., Chichester K.L., Bieneman A.P., Huang S.K., Wood R.A., Schroeder J.T. Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells. J. Allergy Clin. Immunol. 2009, 123:217-223.
30. Novak N., Haberstok J., Bieber T., Allam J.P. The immune privilege of the oral mucosa. Trends Mol. Med. 2008, 14:191-198.
31. Allam J.P., Niederhagen B., Bucheler M., Appel T., Betten H., Bieber T., Berge S., Novak N. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006, 61:166-172.
32. Krishnamoorthy N., Oriss T.B., Paglia M., Fei M., Yarlagadda M., Vanhaesebroeck B., Ray A., Ray P. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 2008, 14:565-573.
33. +CD25 T cells. J. Immunol. 2007, 179:2041-2045.
34. Dreschler K., Bratke K., Petermann S., Bier A., Thamm P., Kuepper M., Virchow J.C., Lommatzsch M. Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy. J. Allergy Clin. Immunol. 2011, 127:487-494. (e481-483).
35. Francis J.N., James L.K., Paraskevopoulos G., Wong C., Calderon M.A., Durham S.R., Till S.J. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J. Allergy Clin. Immunol. 2008, 121:1120-1125. (e1122).
36. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 2007, 120:707-713.
37. Bedoret D., Singh A.K., Shaw V., Hoyte E.G., Hamilton R., DeKruyff R.H., Schneider L.C., Nadeau K.C., Umetsu D.T. Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol. 2012, 5:267-276.
38. Blumchen K., Ulbricht H., Staden U., Dobberstein K., Beschorner J., de Oliveira L.C., Shreffler W.G., Sampson H.A., Niggemann B., Wahn U., Beyer K. Oral peanut immunotherapy in children with peanut anaphylaxis. J. Allergy Clin. Immunol. 2010, 126:83-91. (e81).
39. Suarez-Fueyo A., Ramos T., Galan A., Jimeno L., Wurtzen P.A., Marin A., de Frutos C., Blanco C., Carrera A.C., Barber D., Varona R. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J. Allergy Clin. Immunol. 2014, 133:130-138. (e131-132).
40. Bao M., Hanabuchi S., Facchinetti V., Du Q., Bover L., Plumas J., Chaperot L., Cao W., Qin J., Sun S.C., Liu Y.J. CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J. Immunol. 2012, 189:786-792.
41. Ambarus C.A., Santegoets K.C., van Bon L., Wenink M.H., Tak P.P., Radstake T.R., Baeten D.L. Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10. PLoS One 2012, 7:e35994.
42. Wenink M.H., Santegoets K.C., Roelofs M.F., Huijbens R., Koenen H.J., van Beek R., Joosten I., Meyer-Wentrup F., Mathsson L., Ronnelid J., Adema G.J., Bonvini E., Koenig S., van den Berg W.B., van Riel P.L., Radstake T.R. The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease. J. Immunol. 2009, 183:4509-4520.
43. Maggi E. T-cell responses induced by allergen-specific immunotherapy. Clin. Exp. Immunol. 2010, 161:10-18.
44. Trompette A., Divanovic S., Visintin A., Blanchard C., Hegde R.S., Madan R., Thorne P.S., Wills-Karp M., Gioannini T.L., Weiss J.P., Karp C.L. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009, 457:585-588.